Ambu A/S (OTCMKTS:AMBBY) Shares Gap Down – Time to Sell?

Shares of Ambu A/S Unsponsored ADR (OTCMKTS:AMBBYGet Free Report) gapped down prior to trading on Friday . The stock had previously closed at $12.54, but opened at $11.7350. Ambu A/S shares last traded at $11.7350, with a volume of 500 shares.

Ambu A/S Trading Down 6.4%

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.67 and a current ratio of 2.86. The stock’s 50-day simple moving average is $13.24 and its 200-day simple moving average is $14.23. The firm has a market capitalization of $2.76 billion, a PE ratio of 37.85 and a beta of 0.98.

Ambu A/S (OTCMKTS:AMBBYGet Free Report) last posted its earnings results on Wednesday, February 4th. The company reported $0.07 EPS for the quarter. The firm had revenue of $242.85 million during the quarter. Ambu A/S had a net margin of 8.86% and a return on equity of 9.15%.

Ambu A/S Company Profile

(Get Free Report)

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.

Featured Stories

Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.